Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Prostate cancer radiomics and the promise of radiogenomics.

Stoyanova R, Takhar M, Tschudi Y, Ford JC, Solórzano G, Erho N, Balagurunathan Y, Punnen S, Davicioni E, Gillies RJ, Pollack A.

Transl Cancer Res. 2016 Aug;5(4):432-447.

2.

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.

Yang F, Ford JC, Dogan N, Padgett KR, Breto AL, Abramowitz MC, Dal Pra A, Pollack A, Stoyanova R.

Transl Androl Urol. 2018 Jun;7(3):445-458. doi: 10.21037/tau.2018.06.05. Review.

3.

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.

Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam LL, Alshalalfa M, Buerki C, Castillo R, Jorda M, Ashab HA, Kryvenko ON, Punnen S, Parekh DJ, Abramowitz MC, Gillies RJ, Davicioni E, Erho N, Ishkanian A.

Oncotarget. 2016 Aug 16;7(33):53362-53376. doi: 10.18632/oncotarget.10523.

4.

Radiomics based targeted radiotherapy planning (Rad-TRaP): a computational framework for prostate cancer treatment planning with MRI.

Shiradkar R, Podder TK, Algohary A, Viswanath S, Ellis RJ, Madabhushi A.

Radiat Oncol. 2016 Nov 10;11(1):148.

5.

Multiparametric MRI and radiomics in prostate cancer: a review.

Sun Y, Reynolds HM, Parameswaran B, Wraith D, Finnegan ME, Williams S, Haworth A.

Australas Phys Eng Sci Med. 2019 Mar;42(1):3-25. doi: 10.1007/s13246-019-00730-z. Epub 2019 Feb 14.

PMID:
30762223
6.

Entering an era of radiogenomics in prostate cancer risk stratification.

Soodana-Prakash N, Stoyanova R, Bhat A, Velasquez MC, Kineish OE, Pollack A, Parekh DJ, Punnen S.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S443-S452. doi: 10.21037/tau.2018.07.04. Review.

7.

Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).

Dwivedi DK, Kumar R, Bora GS, Thulkar S, Sharma S, Gupta SD, Jagannathan NR.

NMR Biomed. 2016 Mar;29(3):232-8. doi: 10.1002/nbm.3452. Epub 2016 Jan 5.

PMID:
26730884
8.

Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment.

Bjurlin MA, Mendhiratta N, Wysock JS, Taneja SS.

Cent European J Urol. 2016;69(1):9-18. doi: 10.5173/ceju.2016.734. Epub 2016 Jan 25. Review.

9.

Using multiparametric MRI to 'personalize' biopsy for men.

Mendhiratta N, Meng X, Taneja SS.

Curr Opin Urol. 2015 Nov;25(6):498-503. doi: 10.1097/MOU.0000000000000216. Review.

PMID:
26414608
10.

MAPS: A Quantitative Radiomics Approach for Prostate Cancer Detection.

Cameron A, Khalvati F, Haider MA, Wong A.

IEEE Trans Biomed Eng. 2016 Jun;63(6):1145-56. doi: 10.1109/TBME.2015.2485779. Epub 2015 Oct 1.

PMID:
26441442
11.

Radiomics and radiogenomics of prostate cancer.

Smith CP, Czarniecki M, Mehralivand S, Stoyanova R, Choyke PL, Harmon S, Turkbey B.

Abdom Radiol (NY). 2018 Jun 20. doi: 10.1007/s00261-018-1660-7. [Epub ahead of print]

PMID:
29926137
12.

Objective risk stratification of prostate cancer using machine learning and radiomics applied to multiparametric magnetic resonance images.

Varghese B, Chen F, Hwang D, Palmer SL, De Castro Abreu AL, Ukimura O, Aron M, Aron M, Gill I, Duddalwar V, Pandey G.

Sci Rep. 2019 Feb 7;9(1):1570. doi: 10.1038/s41598-018-38381-x.

13.

The current and future role of magnetic resonance imaging in prostate cancer detection and management.

Radtke JP, Teber D, Hohenfellner M, Hadaschik BA.

Transl Androl Urol. 2015 Jun;4(3):326-41. doi: 10.3978/j.issn.2223-4683.2015.06.05. Review.

14.

Radiomics and radiogenomics for precision radiotherapy.

Wu J, Tha KK, Xing L, Li R.

J Radiat Res. 2018 Mar 1;59(suppl_1):i25-i31. doi: 10.1093/jrr/rrx102.

15.

The role of MRI in active surveillance for men with localized prostate cancer.

Recabal P, Ehdaie B.

Curr Opin Urol. 2015 Nov;25(6):504-9. doi: 10.1097/MOU.0000000000000221. Review.

PMID:
26372037
16.

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.

BJU Int. 2014 Feb;113(2):218-27. doi: 10.1111/bju.12243. Epub 2013 Nov 13.

17.

Multiparametric MRI in detection and staging of prostate cancer.

Boesen L.

Dan Med J. 2017 Feb;64(2). pii: B5327. Review.

PMID:
28157066
18.

Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.

Horvat N, Bates DDB, Petkovska I.

Abdom Radiol (NY). 2019 May 4. doi: 10.1007/s00261-019-02042-y. [Epub ahead of print]

PMID:
31055615
19.

Background, current role, and potential applications of radiogenomics.

Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA.

J Magn Reson Imaging. 2018 Mar;47(3):604-620. doi: 10.1002/jmri.25870. Epub 2017 Nov 2. Review.

20.

Multi-parametric MRI imaging of the prostate-implications for focal therapy.

Wysock JS, Lepor H.

Transl Androl Urol. 2017 Jun;6(3):453-463. doi: 10.21037/tau.2017.04.29. Review.

Supplemental Content

Support Center